Causes of mortality related to peptic ulcer bleeding in a prospective cohort of 965 french patients: A plea for primary prevention

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1902-1903

  Nahon, Stéphane ^a   Pariente, Alexandre ^b   Nalet, Bernard ^b   Hagège, Hervé ^c   Latrive, Jean Paul ^b  

^a Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

^b CENTRE HOSPITALIER   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ADULT; CARDIOPULMONARY ARREST; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRUG MEGADOSE; DUODENAL ULCER BLEEDING; DUODENUM ULCER; FEMALE; FRANCE; GASTRIC ULCER BLEEDING; HOSPITALIZATION; HUMAN; LETTER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PEPTIC ULCER BLEEDING; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; STOMACH ULCER; UPPER GASTROINTESTINAL BLEEDING;

AGED; CAUSE OF DEATH; COMORBIDITY; FEMALE; FRANCE; GASTROSCOPY; HUMANS; LOGISTIC MODELS; MALE; PEPTIC ULCER HEMORRHAGE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955370994     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.115     Document Type: Letter

References (3)

1. Sung JJ, Tsoi KK, Ma TK et al. Causes ofmortality in patients with peptic ulcer bleeding:a prospective cohort study of 10,428 cases. Am JGastroenterol 2010; 105: 84-89
2. Nahon S, Nouel O, Hag è ge H, et al., Groupedes H é morragies Digestives Hautes del'Association Nationale des H é patogastroentérologues des hô pitaux G énéraux. Favorableprognosis of upper-gastrointestinal bleedingin 1041 older patients: results of a prospectivemulticenter study. Clin Gastroenterol Hepatol2008; 6: 886-892
3. Rostom A, Moayyedi P, Hunt R, CanadianAssociation of Gastroenterology ConsensusGroup. Canadian consensus guidelines onlong-term nonsteroidal anti-inflammatorydrug therapy and the need for gastroprotection:benefits versus risks. Aliment Pharmacol Ther2009; 29: 481-496